mHealth Intervention for Improving Eye Health at Community Level (Vison mHealth)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03922347|
Recruitment Status : Completed
First Posted : April 19, 2019
Last Update Posted : April 23, 2019
This study is a community trial that aims to establish and evaluate an mHealth screening and promotional tool for improving eye health in Iran. Sampling frame is a region in Tehran province with around 1 million sub-urban and rural inhabitants. investigators have obtained the list of health centers and their underserved population from the health authorities. In this region, health services are delivered through rural health houses, urban health posts and overhead health centers (221 units in total). investigators choose 27 units using cluster random sampling method with a probability proportional to size strategy, then investigators randomly assign them into three arms (explained below). The interventions will be at community level with the community as the unit of randomization.
Arm 1- Training of the Primary Health Care (PHC) workers + PHC workers will be empowered with the mHealth tool to monitor, screen and promote community members Arm 2- PHC system will be strengthened with health promotion and screening programmes (same content as the mHealth tool) and PHC workers will deliver eye health messages and screening tests by the conventional facilities.
Arm 3: Control group: only observation and registering of routine care
|Condition or disease||Intervention/treatment||Phase|
|Visual Impairment||Diagnostic Test: Screening program including 2 consecutive tests Diagnostic Test: Screening program with mobile health||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Modelling and Evaluation of a Community-oriented mHealth-based Screening and Promotional Programme for Improving Eye Health in Iran|
|Actual Study Start Date :||April 15, 2017|
|Actual Primary Completion Date :||May 15, 2018|
|Actual Study Completion Date :||April 10, 2019|
|No Intervention: routine care|
|Active Comparator: Screening program including 2 consecutive tests||
Diagnostic Test: Screening program including 2 consecutive tests
visual acuity test by Snellen chart, fundus imaging by fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)
|Active Comparator: Screening program with mobile health||
Diagnostic Test: Screening program with mobile health
Peek Acuity and Peek Retina installed on smart phones (Samsung Galaxy S8)
- Eye care utilization: being visited/treated by an eye care professional [ Time Frame: 6-12 months ]Questionnaire based on closed questions
- Visual acuity [ Time Frame: At baseline ]
Peek Acuity Software installed on smart phones (Samsung Galaxy S8, based on Logarithm Minimum Angle of Resolution, LogMAR). Visual acuity will be presented in range (minimum to maximum).
Higher value of visual acuity represents the worsened outcome.
- fundus imaging [ Time Frame: At baseline ]Peek Retina Software installed on smart phones (Samsung Galaxy S8; based on Logarithm Minimum Angle of Resolution, LogMAR). Higher value of visual acuity represents the worsened outcome.
- Based on Logarithm Minimum Angle of Resolution, LogMAR. Visual acuity will be presented in range (minimum to maximum). Higher value of visual acuity represents the worsened outcome. [ Time Frame: At baseline ]visual acuity test by Snellen chart
- fundus imaging by fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany) [ Time Frame: At baseline ]fundus photography (Visucam Pro NM; Carl Zeiss Meditec AG, Germany)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03922347
|Iran, Islamic Republic of|
|Ophthalmic Research Center|
|Tehran, Iran, Islamic Republic of|